Table 2 Summary of clinical and histological findings on number of animals affected in the study groups
From: Safety of ilunocitinib tablets (Zenrelia™) after once daily oral administration in dogs
0X | 1X | 2X | 3X | 5X | |
|---|---|---|---|---|---|
Skin discoloration | 0 | 1 | 1 | 2 | 0 |
Skin lesion | 2 | 4 | 5 | 6 | 8 |
Skin lesion w/discharge | 1 | 1 | 3 | 3 | 4 |
Swollen paws | 1 | 1 | 5 | 6 | 3 |
Skin thickening (paws) | 1 | 0 | 1 | 1 | 0 |
Skin scab paw | 2 | 0 | 0 | 1 | 1 |
Papilloma | 0 | 0 | 0 | 1 | 2 |
Folliculitis/furunculosis | 0 | 0 | 0 | 0 | 3 |